Glucocorticoid receptor cofactors as therapeutic targets

Curr Opin Pharmacol. 2010 Dec;10(6):613-9. doi: 10.1016/j.coph.2010.08.001. Epub 2010 Aug 26.

Abstract

Numerous transcriptional cofactors (e.g. coactivators, corepressors, and comodulators) are known to alter the maximal transcriptional activity (A(max)) in gene induction and repression by steroid receptors in general and glucocorticoid receptors (GRs) in particular. However, recent data advance the earlier reports that these same factors also modify other parameters of glucocorticoid receptor transcriptional activity: the potency of agonists (or EC₅₀ and the partial agonist activity of antisteroids (or PAA). In several instances, factors modulate the EC₅₀ and/or PAA without changing A(max). Thus, studies of all three parameters reveal new factors acting at various stages of receptor action, thereby increasing the potential therapeutic targets for adjusting GR actions in pathological situations.

Publication types

  • Research Support, N.I.H., Intramural
  • Review

MeSH terms

  • Animals
  • Cell Line
  • Co-Repressor Proteins / genetics
  • Co-Repressor Proteins / metabolism*
  • Drug Partial Agonism
  • Gene Expression / drug effects
  • Glucocorticoids / pharmacology
  • Humans
  • Nuclear Receptor Coactivators / genetics
  • Nuclear Receptor Coactivators / metabolism*
  • Protein Binding
  • Receptors, Glucocorticoid / agonists
  • Receptors, Glucocorticoid / genetics
  • Receptors, Glucocorticoid / metabolism*
  • Repressor Proteins / genetics
  • Repressor Proteins / metabolism
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Transcription, Genetic / drug effects

Substances

  • Co-Repressor Proteins
  • Glucocorticoids
  • Nuclear Receptor Coactivators
  • Receptors, Glucocorticoid
  • Repressor Proteins
  • Transcription Factors